1. Roehrborn CG, Mc Connel J, Barry MJ, et al. Guideline on the Management of Benign Prostatic Hypertrophy. AUA website: http://www.auanet.org/content/guidelines-and-quality-care/clinical-guidelines/main-reports/bph-management/preface_toc.pdf.
2. Lower urinary tract symptoms suggestive of benign prostatic hyperplasia: latest updated on α1-adrenoceptor antagonists;Milani;BJU Int,2005
3. Tamsulosin—modified-release and oral-controlled absorption system formulation in the treatment of benign prostatic hyperplasia;van Dijk;Therapy,2006
4. A meta-analysis of the vascular-related safety profile and efficacy of α-adrenergic blockers for symptoms related to benign prostatic hyperplasia;Nickel;Int J Clin Pract,2008
5. α1-α2- and β-Adrenoceptors in the urinary bladder, urethra and prostate;Michel;Br J Pharmacol,2006